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Available online 2 July 2015AbstractObjective: To investigate the variance of metablites, including N-Acetyl aspartate (NAA), Choline (Cho) and Creatine (Cr), in brain regions of
HIV infected patients with non-cognitive disorder and healthy volunteers by a 3.0 T magnetic resonance spectroscopy.
Methods: Single voxel magnetic resonance spectroscopy was applied to measure the basal ganglia region, frontal lobe and parietal lobe in 69
HIV infected patients and 33 healthy volunteers. According to CD4 T cell count, the patients were divided into 2 groups, group A (200 cells/
mL, 40 patients) and group B (<200 cells/mL, 29 patients). The normal control group, group C, consisted of 33 healthy volunteers.
Results: The patients in groups A and B had lower ratio of NAA/Cr but higher ratio of Cho/Cr in the basal ganglia region than group C
(P < 0.001; P ¼ 0.021). Compared to groups B and C, the patients in group A had higher ratios of NAA/Cr and Cho/Cr (P ¼ 0.013; P < 0.001) in
the frontal lobe. In the parietal lobe, the patients in group A had higher ratio of Cho/Cr than groups B and C (P ¼ 0.037).
Conclusion: HIV infection induces inflammation in basal ganglia region, frontal lobe and parietal lobe before non-cognitive disorder occurs after
HIV infection. However, the basal ganga region sees more neurons loss.
© 2015 The Authors. Production and hosting by Elsevier B.V. On behalf of Beijing You’an Hospital affiliated to Capital Medical University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: HIV infection; MR spectroscopy; Cognitive disorder; N-Acetyl aspartate; Choline1. Introduction
Due to the widespread use of highly active antiretroviral
therapy (HAART) for HIV infected patients in China, the
incidence of HIV/AIDS associated neurocognitive disorder
(HAND) has been showing a gradual increase nowadays [1].
By studies intended to find the evidence for early diagnosis of
HAND, intracephalic metabolic changes have been demon-
strated to occur before HAND [2].
2. Materials and methods
A total of 69 HIV infected patients was enrolled in our
present study, including 23 females and 46 males with a* Corresponding author.
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open access article under the CC BY-NC-ND license (http://creativecommons.org/median age of 39 years (range: 23e63 years). The diagnosis of
HIV infection was defined 2 weeks to 19 years ago. The pa-
tients with a mild condition, specifically a CD4 T cell count of
above 200 cells/mL (200 cells/mL), were assigned into group
A. The patients with a CD4 T cell count of <200 cells/mL,
namely patients with severe condition, were assigned into
group B. Healthy volunteers were recruited to constitute the
normal control group, the group C, including 11 females and
22 males with a median age of 35 years (range: 22e59 years).
By using Siemens 3.0 T TIM TRIO magnetic resonance
scanner with 32 channel head coil, single voxel magnetic
resonance spectroscopy (MRS) imaging was performed in
cerebral axis T2WI and 3-dimensional model voxel. The
basal ganglia, the frontal lobe and parietal lobe were scan-
ned. The scanning parameters of T2WI (TSE, fast spin echo)
was TR/TE 4570/100 ms, 5 mm of layer thickness and
1.5 mm interval, while the scan parameters of 3-dimensional
model voxel T1WI (TurboFLASH, fast and small angleof Beijing You’an Hospital affiliated to Capital Medical University. This is an
licenses/by-nc-nd/4.0/).
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250 mm  250 mm and voxel 1.0 mm  1.0 mm  1.0 mm.
The scan parameters of MRS was Svs-se (Press sequence),
TR/TE 2000/135 ms, number of excitation of 64 and band-
width 1200 Hz with 20 mm * 20 mm * 20 mm volume of
voxel. MRS was processed into wave spectrogram by the use
of syngo B17 spectroscopy. The quality of MRS figure was
accessed by an experienced radiologist who was also
responsible for observing MRI plain scan and MRS figure.
The values of NAA, Cho and Cr were recorded.
The recruitment criteria of HIV infected patients included:
HIV positive and at least 10 points scoring for the, interna-
tional HIV dementia scale (IHDS) [3]. According to MR
T1WI and T2WI, the patients with obvious lesions of cerebral
infection and/or obvious space occupying effect were
excluded. The recruitment criteria for healthy volunteers
included: no history of cerebrocardiovascular events, no brain
parenchymal lesions on weighted T1 and/or T2 image when
large noise was excluded, instability of base line or peak
overlapping by MRS.
Statistical analysis was performed by using SPSS 16. T test
was used for hypothesis test when the data was in line with
normal distribution.
3. Results
The group A consisted of 40 patients, including 20 males
and 20 females, with a median age of 37.5 years (range:
25e63 years). A total of 13 patients reported a history of
unsafe homosexual/heterosexual behavior, and 2 other patients
reported a history of receiving blood transfusion. TheFig. 1. A female patient aged 47 years with HIV infection for 8 years. She was treate
MRS of basal ganglia showed lower NAA and higher Cho.remaining 25 patients reported no known infection route.
Their durations of HIV infection ranged from 3 months to 19
years with a median of 60 months. The CD4 T cell counts in
the group A ranged from 202 cells/mL to 1200 cells/mL and 14
patients from the group A had a CD4 T cell count of 500
cells/mL (Fig. 1). And 10 patients from the group A reported a
history of intracranial infection. The group B consisted of 29
patients with a median age of 40 years (range: 23e60 years).
The 18 patients reported a history of unsafe homosexual or
heterosexual behavior and another 1 patient reported a history
of receiving blood transfusion. The other 10 patients showed
no known route of HIV infection. Their durations of HIV
infection ranged from 2 weeks to 19 years with a median of 2
months. The CD4 T cell count of the patients in the group B
ranged from 3 to 194 cells/mL. Notably, 24 patients in this
group had a history of intracranial infection. MRS showed no
lactate peak in all the cases (Table 1).
4. Discussion
In the era of HAART, most HIV infected patients experi-
ence symptoms of the central nervous system [4]. When HIV
infected patients are receiving HAART, 50% shows lower
cognitive ability than the healthy controls of the same age [4].
HIV infection may impair the central nervous system to pro-
duce cognitive and behavioral impairment, and even dementia.
MRS is optimal in diagnosing HIV-related dementia [5,6]. In
recent years, MRS has gained widespread application in an-
tiretroviral therapy [7], as well as the detecting of cerebral
metabolism during its early period (within 1 year) and chronic
period [8]. Our present study intended to evaluate thed by antiretroviral therapy for 7 years. The CD4 T cell count was 500 cells/mL.
Table 1
Analysis of intracranial infection in all the cases.
CD4þ T cell
(cells/mL)
Basal ganglia Frontal lobe Parietal lobe
Cases NAA/Cr Cho/Cr NAA/Cr Cases NAA/Cr Cho/Cr NAA/Cr Cases NAA/Cr Cho/Cr NAA/Cr
200 (A group) 29 1.36 ± 0.28 0.96 ± 0.19 1.45 ± 0.33 36 1.84 ± 0.20 1.19 ± 0.14 1.56 ± 0.19 37 2.05 ± 0.25 1.11 ± 0.16 1.88 ± 0.39
<200 (B group) 13 1.15 ± 0.28 0.98 ± 0.13 1.18 ± 0.25 22 1.66 ± 0.33 1.01 ± 0.18 1.69 ± 0.38 26 1.92 ± 0.22 1.03 ± 0.20 1.91 ± 0.36
Normal group
(C group)
21 1.55 ± 0.22 0.84 ± 0.17 1.88 ± 0.29 33 1.73 ± 0.14 1.06 ± 0.13 1.66 ± 0.22 33 1.94 ± 0.18 1.02 ± 0.10 1.92 ± 0.24
P value (ANOVA) <0.001 0.023 <0.001 0.013 <0.001 0.135 0.051 0.037 0.783
P value (AeB) 0.021 0.678 0.010 0.005 <0.001 0.077 0.030 0.042 0.595
P value (AeC) 0.016 0.017 <0.001 0.049 <0.001 0.110 0.051 0.021 0.522
P value (BeC) <0.001 0.020 <0.001 0.277 0.298 0.730 0.726 0.902 0.948
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detected by MRS in diagnosing or assessing HIV infected
patients with no cognitive impairment. A longer TE time
(135 ms) was selected for the subjects of the study, accounting
for a more stable basic line and a better reproducibility of the
waveform of the main markers.
MRS is capable of demonstrating early cerebral trauma [8].
Even though MRS remains to be the only noninvasive exam-
ination for cerebral metabolism, the scanning can be greatly
affected by the uniformity of magnetic field, the conditions of
patient, and the scanning parameters. The neuropsychological
examination is an additional way to MRS in the diagnosis of
HIV/AIDS related dementia. In the studies about the use of
MRS in detecting cerebral cognitive impairment, the data
about basal ganglia and hippocampus tended to be consistent,
suggesting that HIV infection could induce lower NAA/Cr.
However, the studies showed variant MRS data about the
frontal lobe, occipital lobe and cingulate cortex. Morgan [9]
found that frontal lobe has higher inositol and lower gluta-
mate complex but absence of NAA. However, Lentz [10] and
Suwanwela [11] found that frontal lobe shows lower NAA in
the early period of HIV infection.
The group of patients with mild condition was shown with
higher Cho/Cr in basal ganglia, frontal lobe and parietal lobe
than the normal control group. However, the group of patients
with severe condition was shown with higher Cho/Cr only in
basal ganglia. Because of the longer duration of HIV infection
in the group of patients with mild condition, inflammation
induced by HIV infection may contribute to the increase of
Cho/Cr ratio. In combination to the ratio of NAA/Cr (no
obvious decrease in frontal lobe), the frontal lobe of HIV
infected patients with no symptomatic cognitive impairment
showed inflammation induced by HIV virus, but no loss of
neuron was demonstrated.
Based on grouping of patients by the CD4 T cell count,
our study demonstrated that the basal ganglia of HIV infected
patients, including those with high CD4 T cell count and low
CD4 T cell count, has lower NAA/Cr than the normal con-
trol. And the decrease of NAA/Cr ratio is more obvious in the
group of patients with lower CD4 T cell count (1.15/1.55).
The finding indicated neuronal trauma in basal ganglia of
HIV infected patients with no cognitive impairment, whose
occurrence is not related to CD4 T cell count. Our finding is
consistent to the results of most related studies. The frontallobe of HIV infected patients with low CD4 T cell count was
shown to have lower NAA/Cr than HIV infected patients with
high CD4 T cell count, but no significant decrease by com-
parison to the normal control. The reason for such changes
may be related to exclusion of HIV infected patients with
cognitive impairment in our study. Therefore, we speculated
that the frontal lobe of HIV infected patients with no
cognitive impairment may experience mild neuronal trauma.
The parietal lobe of the patients with low CD4 T cell count
was shown with lower NAA/Cr than the patients with high
CD4 T cell count (P ¼ 0.030). The finding may be related to
the measurement error, due to P (ANOVA) of about 0.051. As
we know, in addition to a large amount of neuron, there are
also a large amount of microglias in the basal ganglia. And in
the brain of HIV infected patients, microglia is seriously
affected by HIV virus. Because the microglia nourishes the
neuron, the trauma of microglia may induce neuronal trauma.
Although HIV virus could destroy the nerve cell of frontal
lobe and parietal lobe, basal ganglia is mainly affected by
HIV virus in the early period of its infection. Based on the
previous reports [12,13], we came to a conclusion that
regarding the central nervous system, HIV virus may spread
from basal ganglia to frontal lobe, parietal lobe and occipital
lobe.
Our findings may be insufficient to explain such an infec-
tion route because MRS with longer TE (135 ms) is incapable
of detecting inositol and glutamate complex. However, the
longer TE (135 ms) facilitates in observing NAA and Cho with
favorable stability and repeatability. The metabolic conditions
of NAA and Cho in the detected regions were precisely
demonstrated in our study. In conclusion, inflammation
induced by HIV infection in basal ganglia, frontal lobe and
parietal lobe may occur before the period of no cognitive
impairment, but the loss of neuron does occur in the region of
cerebral basal ganglia.
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